Options expected to have increasing volume: AMRN ABX GERN NKE

Go back to Options expected to have increasing volume: AMRN ABX GERN NKE

Amarin Corp. (AMRN) Surges 278% on Positive Study Results

September 24, 2018 6:31 AM EDT

Amarin Corp. (NASDAQ: AMRN) is surging 278% in pre-open trade after the company announced topline results from the Vascepa® cardiovascular (CV) outcomes trial, REDUCE-IT, a global... More